643 related articles for article (PubMed ID: 17030185)
1. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction.
Wang F; Schwarz BT; Graham WV; Wang Y; Su L; Clayburgh DR; Abraham C; Turner JR
Gastroenterology; 2006 Oct; 131(4):1153-63. PubMed ID: 17030185
[TBL] [Abstract][Full Text] [Related]
2. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
[TBL] [Abstract][Full Text] [Related]
3. Blockade of hypoxia-inducible factor-1α by YC-1 attenuates interferon-γ and tumor necrosis factor-α-induced intestinal epithelial barrier dysfunction.
Liu H; Li M; Wang P; Wang F
Cytokine; 2011 Dec; 56(3):581-8. PubMed ID: 21890376
[TBL] [Abstract][Full Text] [Related]
4. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.
Schwarz BT; Wang F; Shen L; Clayburgh DR; Su L; Wang Y; Fu YX; Turner JR
Gastroenterology; 2007 Jun; 132(7):2383-94. PubMed ID: 17570213
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression.
Wang F; Graham WV; Wang Y; Witkowski ED; Schwarz BT; Turner JR
Am J Pathol; 2005 Feb; 166(2):409-19. PubMed ID: 15681825
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
Cao M; Wang P; Sun C; He W; Wang F
PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
[TBL] [Abstract][Full Text] [Related]
7. Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis.
Suzuki M; Nagaishi T; Yamazaki M; Onizawa M; Watabe T; Sakamaki Y; Ichinose S; Totsuka M; Oshima S; Okamoto R; Shimonaka M; Yagita H; Nakamura T; Watanabe M
PLoS One; 2014; 9(2):e88369. PubMed ID: 24520376
[TBL] [Abstract][Full Text] [Related]
8. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
[TBL] [Abstract][Full Text] [Related]
9. [An experimental study on intestinal epithelial barrier dysfunction induced by interferon-gamma and tumor necrosis factor-alpha].
Liu H; Wang P; Wang FJ
Zhonghua Shao Shang Za Zhi; 2011 Apr; 27(2):145-9. PubMed ID: 21651851
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of hydrogen sulfide on TNF-α and IFN-γ-induced injury of intestinal epithelial barrier function in Caco-2 monolayers.
Chen SW; Zhu J; Zuo S; Zhang JL; Chen ZY; Chen GW; Wang X; Pan YS; Liu YC; Wang PY
Inflamm Res; 2015 Oct; 64(10):789-97. PubMed ID: 26249853
[TBL] [Abstract][Full Text] [Related]
11. Protective role of oligomycin against intestinal epithelial barrier dysfunction caused by IFN-γ and TNF-α.
Liu H; Wang P; Cao M; Li M; Wang F
Cell Physiol Biochem; 2012; 29(5-6):799-808. PubMed ID: 22613980
[TBL] [Abstract][Full Text] [Related]
12. Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity.
Yu M; Wang Q; Ma Y; Li L; Yu K; Zhang Z; Chen G; Li X; Xiao W; Xu P; Yang H
Int J Biol Sci; 2018; 14(1):69-77. PubMed ID: 29483826
[TBL] [Abstract][Full Text] [Related]
13. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease.
Zolotarevsky Y; Hecht G; Koutsouris A; Gonzalez DE; Quan C; Tom J; Mrsny RJ; Turner JR
Gastroenterology; 2002 Jul; 123(1):163-72. PubMed ID: 12105845
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.
Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC
Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
[TBL] [Abstract][Full Text] [Related]
16. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier.
Boivin MA; Ye D; Kennedy JC; Al-Sadi R; Shepela C; Ma TY
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G590-8. PubMed ID: 17068119
[TBL] [Abstract][Full Text] [Related]
18. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
[TBL] [Abstract][Full Text] [Related]
19. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
